Lixisenatide is effective and safe as add-on treatment to basal insulin in Asian individuals with type 2 diabetes and different body mass indices: a pooled analysis of data from the GetGoal Studies

INTRODUCTION: This analysis aims to investigate the efficacy and safety of once-daily lixisenatide add-on treatment to basal insulin in Asian individuals with type 2 diabetes, by baseline body mass index (BMI). RESEARCH DESIGN AND METHODS: Data from all Asian participants in the placebo-controlled G...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wenhuan, Wang, Weimin, Meng, Ran, Wu, Guangyu, Zhang, Minlu, Zhang, Xia, Yin, Huiqiu, Zhu, Dalong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404431/
https://www.ncbi.nlm.nih.gov/pubmed/34452904
http://dx.doi.org/10.1136/bmjdrc-2021-002290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404431/
https://www.ncbi.nlm.nih.gov/pubmed/34452904
http://dx.doi.org/10.1136/bmjdrc-2021-002290

Ejemplares similares